Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
307
-
Total 13F shares, excl. options
-
65.6M
-
Shares change
-
-4.96M
-
Total reported value, excl. options
-
$3.13B
-
Value change
-
-$232M
-
Put/Call ratio
-
0.83
-
Number of buys
-
163
-
Number of sells
-
-141
-
Price
-
$47.71
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2020
356 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2020.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 307 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.6M shares
of 115M outstanding shares and own 56.97% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.57M shares), VANGUARD GROUP INC (6.99M shares), JANUS HENDERSON GROUP PLC (6.6M shares), WELLINGTON MANAGEMENT GROUP LLP (3.82M shares), STATE STREET CORP (1.95M shares), Van Berkom & Associates Inc. (1.59M shares), AXA (1.46M shares), AMERIPRISE FINANCIAL INC (1.46M shares), Capital Research Global Investors (1.44M shares), and NORDEA INVESTMENT MANAGEMENT AB (1.2M shares).
This table shows the top 307 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.